Longeveron stock jumps on Alzheimer’s trial results
October 05, 2023 at 08:13 AM EDT
Treatment derived from bone marrow shows promise in patients with mild Alzheimer's disease.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |